Overview

• Health teams launched Ervebo ring vaccination in Bulape with an initial 400 doses delivered and roughly 45,000 more approved for shipment.
• Authorities report rising tolls, with briefings citing up to 81 confirmed cases and 28 deaths as of Sept. 15, including infections among health workers.
• WHO and partners have deployed 48 specialists, prepositioned supplies, and rate risk high nationally, moderate regionally, and low globally.
• Treatment centers in Bulape have received courses of the monoclonal antibody Mab114 to support clinical care.
• Response operations face limited access, ultra‑cold chain challenges, and funding shortfalls, with proximity to Tshikapa and the Angolan border elevating spread concerns.